期刊文献+

23例儿童肾移植临床分析 被引量:11

Clinical study of pediatric renal transplantation: a report of 23 cases
原文传递
导出
摘要 目的探讨儿童肾移植的临床特点,提高肾移植效果。方法对23例3~17岁的儿童肾移植资料进行回顾性分析。结果术后随访5d至72个月,平均26.1个月,死亡1例,人、肾1年存活率分别为93.3%和86.6%。术后7例发生急性排斥反应,6例治疗后逆转,1例因并发移植肾静脉栓塞,切除移植肾;2例发生慢性排斥反应,1例移植肾功能丧失,恢复血液透析,另一例仍在随访治疗中;其它并发症有肺部感染4例,心力衰竭2例,肾静脉阻塞2例,肝功能损害2例,急性肾小管坏死1例。结论儿童肾移植具有一定的特殊性,其血管较细、急性排斥反应发生率较高以及药物代谢快等都是应妥善处理的问题。 Objective To investigate the clinical features of pediatric renal transplantation and improve the effect of pediatric renal transplantation. Methods Clinical data of 23 children (3 17 years old) who underwent renal transplantation were retrospectively analyzed. Results In these 23 recipients, 4 cases suffered from pulmonary infection, 2 from heart failure and 2 from transplanted renal vein echmasis. Two patients' liver function was injured and one suffered from acute tubular necrosis. The incidence of acute rejection (AR) was 30.4 % (7/23) and that of chronic rejection (CR) was 8.7 % (2/23). During the follow up of 5 days to 72 months (average of 26.1 months), one died of heart failure and severe pulmonary infection. The 1 year patient and graft survival rate was respectively 93.3 % and 86.6 % . Conclusion Different from renal transplantation in adult, pediatric renal transplantation has special treatment in the operation process. HLA well matching is necessary for a good effect of pediatric renal transplantation. In spite of its high AR incidence, pediatric renal transplantation is an effective treatment with its satisfactory one year graft survival rate. Nevertheless, its long term effect should be improved much more.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2004年第5期305-307,共3页 Chinese Journal of Organ Transplantation
基金 广东省自然科学基金资助(960131)
关键词 肾移植 移植肾 儿童 急性排斥反应 并发症 临床分析 治疗后 结论 特殊性 目的 Kidney transplantation Child Meta analysis
  • 相关文献

参考文献2

二级参考文献8

  • 1Yoshimura N, Oka T. Tacrolimus a new immunosuppressive agent:a review. Immunol Immunopharm, 1990, 10:32-36.
  • 2Okamura N , Tsukada K , Sakaguchi T , et al . Enhanced liver regeneration by tacrolimus can be blocked by interleukin-1α and interleukin-2. Transplant Proc, 1992, 24:413-415.
  • 3Wissing K , Abramowicz D , Broeders N , et al . Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection.Transplantation, 2000, 70 : 464.
  • 4Danovitch GM. The epidemic of cardiovascular disease in chronic renal disease: a challenge to the transplant physician. Graft, 2000,3:170.
  • 5Filler G, Neuschulz I, Vollmer I, et al. Taerolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.Nephrol Dial Transplant, 2000, 15 : 867-871.
  • 6Pirsch JD, Miller J, Deieroi MH, et al. A comparison of tacmlimus(FKS06) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation, 1997, 63:977.
  • 7Vincenti F, Jensik SC, Filo RS, et al. A long-term comparison of tacrolimus and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation, 2002,73 : 775-782.
  • 8Ahsan N , Johnson C , Gonwa T , et al . Randomiaed trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporin oral solution plus mycophrenolate mofetil after cadaveric kidney transplantation: result at 2 years. Transplantation, 2001,72: 245-250.

共引文献23

同被引文献69

引证文献11

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部